Female Stress Urinary Incontinence Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Female Stress Urinary Incontinence (SUI) Devices Market is projected to expand from USD 783.03 Million in 2025 to USD 1.20 billion by 2031, registering a CAGR of 7.51%. These specialized medical products, which include vaginal pessaries, midurethral slings, and urethral bulking agents, are engineered to restore continence by reinforcing the bladder neck or improving urethral closure during physical activity. Growth in this sector is fundamentally fueled by demographic changes, particularly the increasing population of aging women and rising obesity rates, both of which are major risk factors for pelvic floor weakness. Additionally, the market is being propelled by a growing inclination toward minimally invasive surgical options and enhanced patient education regarding effective management strategies.

This strong demand is reinforced by significant prevalence rates that emphasize the urgent need for clinical solutions. According to 'AUANews' in '2025', 'stress urinary incontinence is the most common type of urinary incontinence with a prevalence of over 40% in females who actively participate in physical activities'. Despite these favorable growth prospects, the market confronts considerable obstacles stemming from strict regulatory standards and persistent litigation concerning the safety of transvaginal mesh implants. These issues continue to undermine surgeon confidence and reduce patient willingness to consent to mesh-based procedures.

Market Drivers

The increasing incidence of female stress urinary incontinence (SUI) acts as a primary catalyst for the devices market, generating growing clinical demand worldwide. This demographic strain, heightened by lifestyle factors and an aging female population, requires a wider array of therapeutic interventions. The magnitude of this condition compels healthcare providers to focus on scalable solutions, extending from urethral bulking agents to sophisticated surgical implants. Underscoring this extensive burden, according to UroMems, June 2024, in the 'UroMems Raises Record $47 million in Series C Financing' press release, stress urinary incontinence affects an estimated 40 million Americans and 90 million Europeans. This significant patient population highlights the vital need for effective management strategies, a point further bolstered by workforce statistics; according to the International Continence Society, in 2024, the prevalence of urinary incontinence in working-age professional women is greater than 25%, showing that the condition spans active populations rather than being restricted to the geriatric demographic.

Concurrently, the incorporation of smart and wearable technologies is transforming the market by enabling non-invasive, home-based therapeutic alternatives. As patients increasingly prefer discreet and convenient options over surgery, manufacturers are integrating digital connectivity and biofeedback mechanisms into pelvic floor muscle training devices to improve clinical outcomes and adherence.

This movement toward digital therapeutics mitigates the shortcomings of conventional conservative treatments by offering progress tracking and real-time visualization. Confirming the effectiveness of these modern approaches, according to Axena Health, July 2024, in the 'Axena Health shares new publication that adds more real-world evidence for the Leva Pelvic Health System' announcement, 74 percent of participants using the system experienced symptom improvement. Such innovations not only enhance patient quality of life but also promote the broader acceptance of device-based therapies as a standard first-line treatment.

Market Challenges

Rigorous regulatory standards and continuing litigation concerning the safety of transvaginal mesh implants constitute a major barrier to the advancement of the Global Female Stress Urinary Incontinence (SUI) Devices Market. This complicated landscape inhibits growth by undermining surgeon confidence and discouraging manufacturers from pursuing aggressive product development due to the risk of significant liability claims. As regulatory authorities increase scrutiny and necessitate more robust clinical data for device approval, companies encounter rising compliance costs and extended timelines for market entry. Consequently, this volatility in the legal and regulatory sphere has altered clinical practice patterns, leading many healthcare providers to decrease their use of mesh-based devices in favor of conservative management strategies.

This reduction in procedural volume is demonstrated by recent industry data that underscores the enduring effect of these safety concerns. According to the 'American Urological Association', in '2024', 'the percentage of patients with stress urinary incontinence who underwent a sling procedure continued to decline to roughly 2.0% within the analyzed population'. Such trends suggest that the fear of legal repercussions and regulatory obstacles effectively constrains the addressable market, restricting patient adoption of these devices despite the widespread prevalence of the condition.

Market Trends

The rise of High-Intensity Focused Electromagnetic (HIFEM) Chair Therapies is increasingly shaping the market, providing a fully passive, non-invasive treatment option that differs significantly from active physical therapy. In contrast to traditional conservative management or biofeedback systems that depend on patient compliance and effort, HIFEM technology uses electromagnetic energy to generate thousands of supramaximal pelvic floor muscle contractions during a single in-office session, ensuring consistent therapeutic results without physical exertion. This technology is experiencing fast commercial adoption as clinicians aim to provide effective, zero-downtime solutions for patients who are reluctant to undergo surgery or struggle with voluntary exercise routines. Confirming this growth, according to Aesthetic Medical Practitioner, December 2024, in the 'BTL wins Best Non-Invasive Body Shaping Manufacturer' article, BTL Aesthetics reported having installed over 500 Emsella devices across the Asia-Pacific region alone, highlighting the substantial global traction and provider acceptance of this chair-based therapy.

At the same time, there is a distinct movement toward Disposable and Over-the-Counter (OTC) Vaginal Support Inserts, fueled by rising consumer demand for immediate, on-demand symptom management outside of clinical environments. These mechanical devices offer discreet structural support to the urethra specifically during physical activity, effectively bridging the therapeutic divide between permanent surgical implants and absorbent pads for women desiring autonomy in managing their condition. This trend represents a democratization of care, shifting away from strictly prescription-based models toward accessible, patient-controlled solutions that can be acquired and used without long-term medical commitments. Emphasizing the investment interest in this sector, according to Medical Product Outsourcing, April 2025, in the 'Uresta Debuts New Bladder Support Solution in U.S.' article, Uresta secured $3 million in funding to accelerate the commercialization of its reusable bladder support device, mirroring the industry's shift toward scalable, consumer-focused innovations.

Key Players Profiled in the Female Stress Urinary Incontinence (SUI) Devices Market

• Coloplast
• Boston Scientific
• Cook Medical
• Axonics
• Neomedic
• Mentor
• Hollister
• A.M. Surgical
• Uroplasty Lines

Report Scope

In this report, the Global Female Stress Urinary Incontinence (SUI) Devices Market has been segmented into the following categories:

Female Stress Urinary Incontinence (SUI) Devices Market, by Product Type:

• Urethral Slings
• Catheters
• Vaginal Pessaries
• Others

Female Stress Urinary Incontinence (SUI) Devices Market, by End-user:

• Hospitals & Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others

Female Stress Urinary Incontinence (SUI) Devices Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Female Stress Urinary Incontinence (SUI) Devices Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.